https://www.selleckchem.com/pr....oducts/sb-505124.htm
KIF11 can be used as a positive correlation marker for HCC prognosis and served as a potential therapeutic target. The expression of KIF11 was negatively correlated with the overall survival (OS) and disease-free survival (DFS) and positively correlated with tumor size of HCC patients. KIF11 depletion inhibits cell proliferation and tumor growth in vitro and in vivo. Conclusion. KIF11 can be used as a positive correlation marker for HCC prognosis and served as a potential therapeutic target.Antibody-drug conjugate therapy has attracte
Like
Comment
Share
